Benzyl salicylate (cas 118-58-1): A survey of consumer patch-test sensitization
-
Add time:08/31/2019 Source:sciencedirect.com
The potential of benzyl salicylate, an important fragrance and flavour ingredient, to induce hypersensitivity or to elicit reactions to pre-existing hypersensitivity in the general population was evaluated by analysing patch-test data. Results obtained from fragrance and formulator companies for a total of 10,538 patch tests on benzyl salicylate alone, on a variety of household and personal care consumer products and on fragrance blends containing benzyl salicylate were analysed as part of this survey. No induced or elicited responses directly attributable to benzyl salicylate were observed in the 35 patch tests on benzyl salicylate alone, or in the 10,503 patch tests on consumer products or fragrance blends containing benzyl salicylate. The highest concentration of benzyl salicylate tested in the consumer-product tests was 2 × 10−1%, and benzyl salicylate alone was tested at 10% in ethanol. This study indicates that benzyl salicylate has a very low potential to induce hypersensitivity (‘induced’ reactions) or to elicit reactions presumably attributable to pre-existing sensitization (‘elicited’ reactions) and thus supports the safe use of benzyl salicylate in consumer products and fragrance blends.
We also recommend Trading Suppliers and Manufacturers of Benzyl salicylate (cas 118-58-1). Pls Click Website Link as below: cas 118-58-1 suppliers
Prev:Kinetics for synthesizing Benzyl salicylate (cas 118-58-1) via solid–liquid phase-transfer catalysis
Next:Inhibition of cytochrome P450 3A protein degradation and subsequent increase in enzymatic activity through p38 MAPK activation by acetaminophen and salicylate derivatives) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- The estrogenic potential of salicylate esters and their possible risks in foods and cosmetics09/02/2019
- Inhibition of cytochrome P450 3A protein degradation and subsequent increase in enzymatic activity through p38 MAPK activation by acetaminophen and salicylate derivatives09/01/2019
- Kinetics for synthesizing Benzyl salicylate (cas 118-58-1) via solid–liquid phase-transfer catalysis08/30/2019
- Study of the transformation of two salicylates used in personal care products in chlorinated water08/29/2019
- Kinetics for synthesizing Benzyl salicylate (cas 118-58-1) by third-liquid phase-transfer catalysis08/28/2019
- ReviewFragrance material review on Benzyl salicylate (cas 118-58-1)08/27/2019
- Initial hazard assessment of Benzyl salicylate (cas 118-58-1): In vitro genotoxicity test and combined repeated-dose and reproductive/developmental toxicity screening test in rats08/26/2019
-
Health and Chemical more >
-
Related Products
- Benzyl (1-(aminocarbonyl)-2-hydroxypropyl)carbamate
- Benzyl (1-cyano-1-methylethyl)carbamate
- Benzyl (1R,2S)-3-chloro-2-hydroxy-1-(phenylthiomethyl)propylcarbamate
- Benzyl (2,5-dioxo-1,3-oxazolidin-4-yl)acetate
- Benzyl (2R,3S)-(-)-6-oxo-2,3-diphenyl-4-morpholinecarboxylate
- Benzyl (2R,3S)-(1-carbamoyl-2-hydroxypropyl)carbamate
- Benzyl (2S,3aR,7aS)-octahydroindole-2-carboxylate hydrochloride
- Benzyl (2S,3aR,7aS)-octahydroindole-2-carboxylate hydrochloride
- Benzyl (2S,3R)-(+)-6-oxo-2,3-diphenyl-4-morpholinecarboxylate
- Benzyl (3-aminopropyl)carbamate


